SSY Group Gets Production and Registration Approval for Parkinson's Disease Drug in China
SSY Group Gets Production and Registration Approval for Parkinson's Disease Drug in China
SSY集团在中国获得帕金森氏病药物的生产和注册许可
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册